# US 8,277,926 B2 · Methods for fabricating coatings for drug delivery devices having gradient of hydration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,926 B2
- Document ID: US8277926B2
- Status: Granted
- Kind: B2
- Application number: 12/016,820
- Filed: 2008-01-18
- Published: 2008-06-12
- Granted: 2012-10-02
- Earliest claimed: 2003-11-06
- Assignees: Advanced Cardiovascular Systems, Inc.
- Inventors: Stephen D. Pacetti; Syed F. A. Hossainy; Yiwen Tang; Andrew C. Tung; Thierry Glauser
- Web page: https://patentgrep.com/patent/US8277926B2

## CPC

- A61L 31/10: Macromolecular materials
- A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body
- A61L 2420/08: Coatings comprising two or more layers
- Y10T 428/24942: including components having same physical characteristic in differing degree
- Y10T 428/3154: Of fluorinated addition polymer from unsaturated monomers
- Y10T 428/31544: Addition polymer is perhalogenated
- Y10T 428/31551: Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]
- Y10T 428/31565: Next to polyester [polyethylene terephthalate, etc.]
- Y10T 428/31573: Next to addition polymer of ethylenically unsaturated monomer
- Y10T 428/31576: Ester monomer type [polyvinylacetate, etc.]
- Y10T 428/31786: Of polyester [e.g., alkyd, etc.]
- Y10T 428/31797: Next to addition polymer from unsaturated monomers
- Y10T 428/31855: Of addition polymer from unsaturated monomers
- Y10T 428/31909: Next to second addition polymer from unsaturated monomers
- Y10T 428/31928: Ester, halide or nitrile of addition polymer
- Y10T 428/31935: Ester, halide or nitrile of addition polymer
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A method for fabricating a coating for an implantable medical device is provided comprising applying a first polymer on at least a portion of the device to form a first layer of the coating and applying a second polymer on at least a portion of the first layer to form a second layer of the coating. The second polymer has a lower degree of hydration than the first polymer.

## Claims

### Claim 1

A method for fabricating a coating for an implantable medical device, the method comprising applying a first polymer on at least a portion of the device to form a first layer of the coating, and applying a second polymer on at least a portion of the first layer to form a second layer of the coating, wherein the second polymer has a lower degree of hydration than the first polymer; and
wherein the first or the second polymer comprises a polyorthoester.

### Claim 2 (depends on 1)

The method of claim 1, wherein the implantable medical device is a stent.

### Claim 3 (depends on 1)

The method of claim 1, wherein the degree of hydration of the first polymer is between greater than 0% and about 20% by mass.

### Claim 4 (depends on 1)

The method of claim 1, wherein the degree of hydration of the second polymer is between greater than 0% and about 20% by mass.

### Claim 5 (depends on 1)

The method of claim 1, wherein the first polymer is selected from a group consisting of polyorthoesters, poly(butyleneterephthalate-co-ethylene glycol), poly(ethylene glycol)-block-poly(butyleneterephthalate)-block poly(ethylene glycol), poly(butyl methacrylate) (PBMA), poly(n-butyl methacrylate), poly(ethyl methacrylate), poly(methyl methacrylate), poly(n-propyl methacrylate), polymethacrylates, poly(D,L-lactide), poly(caprolactone), poly(4-hydroxybutyrate), poly(3-hydroxybutyrate), poly(hydroxyvalerate), poly(ethylene-co-vinyl alcohol), poly(vinyl alcohol), polybutyral, poly(ethylene-co-vinyl acetate), poly(vinyl acetate), poly(vinylidene fluoride), poly(vinylidene fluoride-co-hexafluoropropene), poly(vinylidene fluoride-co-chlorotrifluoroethylene), polyurethanes, and blends thereof.

### Claim 6 (depends on 5)

The method of claim 5, wherein the polyorthoesters are products of co-polycondensation of a diketene acetal, a hydroxylated functional compound and a diol.

### Claim 7 (depends on 6)

The method of claim 6, wherein the diketene acetal has a formula
wherein R and R1 are, independently, unsubstituted or substituted straight-chained, branched, or cyclic C1-C8 alkyl radicals, and unsubstituted or substituted aryl radicals.

### Claim 8 (depends on 6)

The method of claim 6, wherein the diketene acetal is selected from a group consisting of 3,9-diethylidene-2,4,8,10-tetraoxaspiro-[5,5]-undecane, 3,9-dipentylidene-2,4,8,10-tetraoxaspiro-[5,5]-heptadecane, 3,9-dibutylidene-2,4,8,10-tetraoxaspiro-[5,5]-pentadecane, 3,9-dipropylidene-2,4,8,10-tetraoxaspiro-[5,5]-tridecane, and mixtures thereof.

### Claim 9 (depends on 6)

The method of claim 6, wherein the hydroxylated functional compound comprises poly(alkylene glycols), poly(ethylene oxide-co-propylene oxide, hydroxylated poly(vinyl pyrrolidone), dextran, dextrin, hyaluronic acid, derivatives of hyaluronic acid, poly(2-hydroxyethyl methacrylate), or mixtures thereof.

### Claim 10 (depends on 9)

The method of claim 9, wherein the poly(alkylene glycols) are selected from a group consisting of poly(ethylene glycol), poly(propylene glycol), poly(propane-1,2-diol), poly(propane-1,3-diol) and poly(tetramethylene glycol).

### Claim 11 (depends on 6)

The method of claim 6, wherein the diol comprises alkylene glycols, oligoalkylene glycols, or cycloaliphatic diols.

### Claim 12 (depends on 11)

The method of claim 11, wherein the alkylene glycols are selected from a group consisting of C2 to C16 α,ω-glycols.

### Claim 13 (depends on 11)

The method of claim 11, wherein the alkylene glycols are selected from a group consisting of ethylene glycol, propane-1,2-diol, propane-1,3-diol, butane-1,4-diol, pentane-1,5-diol, hexane-1,6-diol, heptane-1,7-diol, octane-1,8-diol, nonane-1,9-diol, decane-1,10-diol, undecane-1,1′-diol, dodecane-1,12-diol, tridecane-1,13-diol, tetradecane-1,14-diol, pentadecane-1,15-diol, hexadecane-1,16-diol, butane-1,3-diol, pentane-2,4-diol, hexane-2,5-diol, and mixtures thereof.

### Claim 14 (depends on 11)

The method of claim 11, wherein the oligoalkylene glycols are selected from a group consisting of diethylene glycol, trimethylene glycol, tetramethylene glycol, tetraethylene glycol, poly(tetraethylene glycol), poly(propylene glycol), and mixtures thereof.

### Claim 15 (depends on 11)

The method of claim 11, wherein the cycloaliphatic diols are selected from a group consisting of trans-cyclohexanedimethanol, 1,4-cyclohexanediol, and mixtures thereof.

### Claim 16 (depends on 1)

The method of claim 1, wherein the second polymer is selected from a group consisting of polyorthoesters, poly(butyleneterephthalate-co-ethylene glycol), poly(ethylene glycol)-block-poly(butyleneterephthalate)-block poly(ethylene glycol), polyorthoesters having poly(ethylene glycol) (PEG) incorporated into the polymer backbone, copolymers of alkyl methacrylates and 2-hydroxyethyl methacrylate, copolymers of PEG-acrylates and alkyl methacrylates, copolymers of PEG-methacrylates and alkyl methacrylates, poly(ester-amides) with PEG functionality, derivatives of hyaluronic acid, heparin conjugates, sulfonated polystyrenes, and poly(ethylene-co-vinyl alcohol) with pendant PEG functionality, poly(n-butyl methacrylate), poly(ethyl methacrylate), poly(methyl methacrylate), poly(n-propyl methacrylate), polymethacrylates, poly(D,L-lactide), poly(caprolactone), poly(4-hydroxybutyrate), poly(3-hydroxybutyrate), poly(hydroxyvalerate), poly(ethylene-co-vinyl alcohol), poly(vinyl alcohol), poly(ethylene-co-vinyl acetate), poly(vinyl acetate), poly(vinylidene fluoride), poly(vinylidene fluoride-co-hexafluoropropene), poly(vinylidene fluoride-co-chlorotrifluoroethylene), polyurethanes, and blends thereof.

### Claim 17 (depends on 16)

The method of claim 16, wherein the polyorthoesters are products of co-polycondensation of a diketene acetal, a hydroxylated functional compound and a diol.

### Claim 18 (depends on 17)

The method of claim 17, wherein the diketene acetal has a formula
wherein R and R1 are, independently, unsubstituted or substituted straight-chained, branched, or cyclic C1-C8 alkyl radicals, and unsubstituted or substituted aryl radicals.

### Claim 19 (depends on 17)

The method of claim 17, wherein the diketene acetal is selected from a group consisting of 3,9-diethylidene-2,4,8,10-tetraoxaspiro-[5,5]-undecane, 3,9-dipentylidene-2,4,8,10-tetraoxaspiro-[5,5]-heptadecane, 3,9-dibutylidene-2,4,8,10-tetraoxaspiro-[5,5]-pentadecane, 3,9-dipropylidene-2,4,8,10-tetraoxaspiro-[5,5]-tridecane, and mixtures thereof.

### Claim 20 (depends on 17)

The method of claim 17, wherein the hydroxylated functional compound comprises poly(alkylene glycols), poly(ethylene oxide-co-propylene oxide, hydroxylated poly(vinyl pyrrolidone), dextran, dextrin, hyaluronic acid, derivatives of hyaluronic acid, poly(2-hydroxyethyl methacrylate), or mixtures thereof.

### Claim 21 (depends on 20)

The method of claim 20, wherein the poly(alkylene glycols) are selected from a group consisting of poly(ethylene glycol), poly(propylene glycol), poly(propane-1,2-diol), poly(propane-1,3-diol) and poly(tetramethylene glycol).

### Claim 22 (depends on 17)

The method of claim 17, wherein the diol comprises alkylene glycols, oligoalkylene glycols, or cycloaliphatic diols.

### Claim 23 (depends on 22)

The method of claim 22, wherein the alkylene glycols are selected from a group consisting of C2 to C16 α,ω-glycols.

### Claim 24 (depends on 22)

The method of claim 22, wherein the alkylene glycols are selected from a group consisting of ethylene glycol, propane-1,2-diol, propane-1,3-diol, butane-1,4-diol, pentane-1,5-diol, hexane-1,6-diol, heptane-1,7-diol, octane-1,8-diol, nonane-1,9-diol, decane-1,10-diol, undecane-1,1′-diol, dodecane-1,12-diol, tridecane-1,13-diol, tetradecane-1,14-diol, pentadecane-1,15-diol, hexadecane-1,16-diol, butane-1,3-diol, pentane-2,4-diol, hexane-2,5-diol, and mixtures thereof.

### Claim 25 (depends on 22)

The method of claim 22, wherein the oligoalkylene glycols are selected from a group consisting of diethylene glycol, trimethylene glycol, tetramethylene glycol, tetraethylene glycol, poly(tetraethylene glycol), poly(propylene glycol), and mixtures thereof.

### Claim 26 (depends on 22)

The method of claim 22, wherein the cycloaliphatic diols are selected from a group consisting of trans-cyclohexanedimethanol, 1,4-cyclohexanediol, and mixtures thereof.

### Claim 27 (depends on 1)

The method of claim 1, wherein the first polymer is a polymer having a formula
wherein R and R1, is each, independently, an unsubstituted or substituted straight-chained, branched, or cyclic C1-C8 alkyl radical, or unsubstituted or substituted aryl radical;
R2—O is a non-fouling moiety derived from a hydroxylated functional compound;
R3 is an aliphatic or cycloaliphatic group;
m, n, p, and q are all integers, where the value of m is between 5 and 500, the value of n is between 2 and 350, the value of p is between 1 and 20, and the value of q is between 10 and 550.

### Claim 28 (depends on 27)

The method of claim 27, wherein R2 is a polymethylene structure.

### Claim 29 (depends on 27)

The method of claim 27, wherein the hydroxylated functional compound comprises poly(alkylene glycols), hydroxylated poly(vinyl pyrrolidone), dextran, dextrin, hyaluronic acid, derivatives of hyaluronic acid, poly(2-hydroxymethyl methacrylate), or mixtures thereof.

### Claim 30 (depends on 1)

The method of claim 1, wherein the second polymer is a polymer having a formula
wherein R and R1, is each, independently, an unsubstituted or substituted straight-chained, branched, or cyclic C1-C8 alkyl radical, or unsubstituted or substituted aryl radical;
R2—O is a non-fouling moiety derived from a hydroxylated functional compound;
R3 is an aliphatic or cycloaliphatic group;
m, n, p, and q are all integers, where the value of m is between 5 and 500, the value of n is between 2 and 350, the value of p is between 1 and 20, and the value of q is between 10 and 550.

### Claim 31 (depends on 30)

The method of claim 30, wherein R2 is a polymethylene structure.

### Claim 32 (depends on 30)

The method of claim 30, wherein the hydroxylated functional compound comprises poly(alkylene glycols), hydroxylated poly(vinyl pyrrolidone), dextran, dextrin, hyaluronic acid, derivatives of hyaluronic acid, poly(2-hydroxymethyl methacrylate), or mixtures thereof.

### Claim 33 (depends on 1)

The method of claim 1, additionally including applying a third polymer on at least a portion of the second layer, wherein the third polymer has a lower degree of hydration than the second polymer or a higher degree of hydration than the second polymer.

### Claim 34 (depends on 33)

The method of claim 33, wherein the degree of hydration of the third polymer is between greater than 0 and about 50% by mass.

### Claim 35 (depends on 33)

The method of claim 33, wherein the third polymer is selected from a group consisting of polyorthoesters, poly(butyleneterephthalate-co-ethylene glycol), poly(ethylene glycol)-block-poly(butyleneterephthalate)-block poly(ethylene glycol), polyorthoesters having poly(ethylene glycol) incorporated into the polymer backbone, copolymers of alkyl methacrylates and 2-hydroxyethyl methacrylate, copolymers of poly(ethylene glycol)-acrylates and alkyl methacrylates, copolymers of poly(ethylene glycol)-methacrylates and alkyl methacrylates, poly(ester-amides) with poly(ethylene glycol) functionality, derivatives of hyaluronic acid, heparin conjugates, sulfonated polystyrenes, and poly(ethylene-co-vinyl alcohol) with pendant poly(ethylene glycol) functionality.

### Claim 36 (depends on 35)

The method of claim 35, wherein the polyorthoesters are products of co-polycondensation of a diketene acetal, a hydroxylated functional compound and a diol.

### Claim 37 (depends on 36)

The method of claim 36, wherein the diketene acetal has a formula
wherein R and R1 are, independently, unsubstituted or substituted straight-chained, branched, or cyclic C1-C8 alkyl radicals, and unsubstituted or substituted aryl radicals.

### Claim 38 (depends on 36)

The method of claim 36, wherein the diketene acetal is selected from a group consisting of 3,9-diethylidene-2,4,8,10-tetraoxaspiro-[5,5]-undecane, 3,9-dipentylidene-2,4,8,10-tetraoxaspiro-[5,5]-heptadecane, 3,9-dibutylidene-2,4,8,10-tetraoxaspiro-[5,5]-pentadecane, 3,9-dipropylidene-2,4,8,10-tetraoxaspiro-[5,5]-tridecane, and mixtures thereof.

### Claim 39 (depends on 36)

The method of claim 36, wherein the hydroxylated functional compound comprises poly(alkylene glycols), poly(ethylene oxide-co-propylene oxide, hydroxylated poly(vinyl pyrrolidone), dextran, dextrin, hyaluronic acid, derivatives of hyaluronic acid, poly(2-hydroxyethyl methacrylate), or mixtures thereof.

### Claim 40 (depends on 39)

The method of claim 39, wherein the poly(alkylene glycols) are selected from a group consisting of poly(ethylene glycol), poly(propylene glycol), poly(propane-1,2-diol), poly(propane-1,3-diol) and poly(tetramethylene glycol).

### Claim 41 (depends on 36)

The method of claim 36, wherein the diol comprises alkylene glycols, oligoalkylene glycols, or cycloaliphatic diols.

### Claim 42 (depends on 41)

The method of claim 41, wherein the alkylene glycols are selected from a group consisting of C2 to C16 α,ω-glycols.

### Claim 43 (depends on 41)

The method of claim 41, wherein the alkylene glycols are selected from a group consisting of ethylene glycol, propane-1,2-diol, propane-1,3-diol, butane-1,4-diol, pentane-1,5-diol, hexane-1,6-diol, heptane-1,7-diol, octane-1,8-diol, nonane-1,9-diol, decane-1,10-diol, undecane-1,1′-diol, dodecane-1,12-diol, tridecane-1,13-diol, tetradecane-1,14-diol, pentadecane-1,15-diol, hexadecane-1,16-diol, butane-1,3-diol, pentane-2,4-diol, hexane-2,5-diol, and mixtures thereof.

### Claim 44 (depends on 41)

The method of claim 41, wherein the oligoalkylene glycols are selected from a group consisting of diethylene glycol, trimethylene glycol, tetramethylene glycol, tetraethylene glycol, poly(tetraethylene glycol), poly(propylene glycol), and mixtures thereof.

### Claim 45 (depends on 41)

The method of claim 41, wherein the cycloaliphatic diols are selected from a group consisting of trans-cyclohexanedimethanol, 1,4-cyclohexanediol, and mixtures thereof.

### Claim 46 (depends on 33)

The method of claim 33, wherein the third polymer is a polymer having a formula
wherein R and R1, is each, independently, an unsubstituted or substituted straight-chained, branched, or cyclic C1-C8 alkyl radical, or unsubstituted or substituted aryl radical;
R2—O is a non-fouling moiety derived from a hydroxylated functional compound;
R3 is an aliphatic or cycloaliphatic group;
m, n, p, and q are all integers, where the value of m is between 5 and 500, the value of n is between 2 and 350, the value of p is between 1 and 20, and the value of q is between 10 and 550.

### Claim 47 (depends on 46)

The method of claim 46, wherein R2 is a polymethylene structure.

### Claim 48 (depends on 46)

The method of claim 46, wherein the hydroxylated functional compound comprises poly(alkylene glycols), hydroxylated poly(vinyl pyrrolidone), dextran, dextrin, hyaluronic acid, derivatives of hyaluronic acid, poly(2-hydroxymethyl methacrylate), or mixtures thereof.

### Claim 49 (depends on 33)

The method of claim 33, wherein the first polymer, the second polymer or the third polymer is selected from a group consisting of poly(hydroxyvalerate), poly(L-lactic acid), polycaprolactone, poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polydioxanone, polyorthoester, polyanhydride, poly(glycolic acid), poly(D,L-lactic acid), poly(glycolic acid-co-trimethylene carbonate), polyphosphoester, polyphosphoester urethane, poly(amino acids), cyanoacrylates, poly(trimethylene carbonate), poly(iminocarbonate), co-poly(ether-esters), polyethylene oxide-co-polylactic acid, polyalkylene oxalates, polyphosphazenes, biomolecules, fibrin, fibrinogen, cellulose, starch, collagen, hyaluronic acid, polyurethanes, silicones, polyesters, polyolefins, polyisobutylene, ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers and copolymers, polyvinyl chloride, polyvinyl ethers, polyvinyl methyl ether, polyvinylidene halides, polyvinylidene fluoride, poly(vinylidene fluoride-co-hexafluoropropene), poly(vinylidene fluoride-co-chlorotrifluoroethylene), polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polystyrene, polyvinyl esters, polyvinyl acetate, copolymers of vinyl monomers with each other and olefins, ethylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS resins, ethylene-vinyl acetate copolymers, polyamides, Nylon 66, polycaprolactam, alkyd resins, polycarbonates, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, soluble fluorinated polymers and carboxymethyl cellulose.
